It is, therefore, predictable that the RYR2 mutations observed in ARVD2 patients enhance Ca2+ leakage and increase spontaneous SR Ca2+ release, thereby leading to DADs and ventricular arrhythmia [51]. The gene discussed is RYR2; the disease is Ventricular arrhythmia.